Auto-injector devices for
intramuscular and subcutaneous administration

Auto-injectors for intramuscular and subcutaneous administration.

Our extensive experience with auto-injectors spans decades.

At Owen Mumford Pharmaceutical Services we have considerable experience in designing and manufacturing both reusable and disposable auto-injectors for subcutaneous and intramuscular drug delivery. Our first introduction was in 1986 with Auto-injector® and since then we have worked with some of the top pharmaceutical and biotech companies producing bespoke devices for use with their key drugs. 

Auto-injectors designed for a range of treatments for patient self-administration

Our range of advanced auto-injector devices support patient self-injection, designed to make the injection experience simple, convenient and more manageable. They can be used to deliver a range of different syringe-based medications. Our Autoject® 2 platform has been key to achieving this and has been used for treatment of multiple therapies including rheumatoid arthritis, multiple sclerosis, growth hormone and anaphylaxis.

Now to align with current market needs we have developed Aidaptus® a disposable platform auto-injector that can be used with both 1mL and 2.25mL syringes to treat patients across a range of therapy areas. By consistently manufacturing high quality devices we have built a reputation of trust with our end-users and partners. 

Aidaptus

Aidaptus®

Aidaptus® versatile design, intuitive delivery.
Read More

To find out more about our
auto-injector technologies please see below

Auto-injectors collage image
Drug Delivery - Spring type and position
Needle protection and needlestick prevention
Pre-activation safety features
Activation mode
Needle Insertion
Arming the auto-injector
Dosing
Type of Device
Additional Features

Auto-injectors designed for a range of treatments for patient self-administration

Our range of advanced auto-injector devices support patient self-injection, designed to make the injection experience simple, convenient and more manageable. They can be used to deliver a range of different syringe-based medications. Our Autoject® 2 platform has been key to achieving this and has been used for treatment of multiple therapies including rheumatoid arthritis, multiple sclerosis, growth hormone and anaphylaxis.

Now to align with current market needs we have developed Aidaptus® a disposable platform auto-injector that can be used with both 1mL and 2.25mL syringes to treat patients across a range of therapy areas. By consistently manufacturing high quality devices we have built a reputation of trust with our end-users and partners. 
 

 

 

 

Aidaptus®

Read More